| Ariel F Soriano, MD | |
|
1000 Pole Creek Xing, Sidney, NE 69162-2901 | |
| (308) 254-5825 | |
| (308) 254-7268 |
| Full Name | Ariel F Soriano |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 32 Years |
| Location | 1000 Pole Creek Xing, Sidney, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558345199 | NPI | - | NPPES |
| 10027127800 | Medicaid | NE | |
| DE3754 | Other | CO | MEDICARE RAILROAD GROUP |
| 01353796 | Medicaid | CO | |
| C830008045 | Other | CO | MEDICARE RAILROAD INDIVID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 34730 (Nebraska) | Primary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 35379 (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sidney Regional Medical Center | Sidney, NE | Hospital |
| Sedgwick County Memorial Hospital | Julesburg, CO | Hospital |
| Regional West Medical Center | Scottsbluff, NE | Hospital |
| Sterling Regional Medcenter | Sterling, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cheyenne County Hospital Association Inc | 1658345657 | 28 |
News Archive
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
BioForce Nanosciences has announced the March sale of the Nano eNabler molecular printer to Louisiana Tech University in Ruston, Louisiana.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
GlucoMen are delighted to announce the launch of an innovative new way for people with diabetes to manage their condition better, with the new GlucoMen Areo blood glucose meter.
The risk of kidney failure caused by multiple myeloma appears to be declining, and survival is lengthening for patients who do develop kidney failure due to this cancer.
› Verified 2 days ago
| Entity Name | Cheyenne County Hospital Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487736963 PECOS PAC ID: 1658345657 Enrollment ID: O20050301000906 |
News Archive
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
BioForce Nanosciences has announced the March sale of the Nano eNabler molecular printer to Louisiana Tech University in Ruston, Louisiana.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
GlucoMen are delighted to announce the launch of an innovative new way for people with diabetes to manage their condition better, with the new GlucoMen Areo blood glucose meter.
The risk of kidney failure caused by multiple myeloma appears to be declining, and survival is lengthening for patients who do develop kidney failure due to this cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ariel F Soriano, MD 1000 Pole Creek Xing, Sidney, NE 69162-2901 Ph: (308) 254-5825 | Ariel F Soriano, MD 1000 Pole Creek Xing, Sidney, NE 69162-2901 Ph: (308) 254-5825 |
News Archive
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
BioForce Nanosciences has announced the March sale of the Nano eNabler molecular printer to Louisiana Tech University in Ruston, Louisiana.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
GlucoMen are delighted to announce the launch of an innovative new way for people with diabetes to manage their condition better, with the new GlucoMen Areo blood glucose meter.
The risk of kidney failure caused by multiple myeloma appears to be declining, and survival is lengthening for patients who do develop kidney failure due to this cancer.
› Verified 2 days ago
Dwaine Smith, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Pole Creek Xing, Sidney, NE 69162 Phone: 308-254-5067 Fax: 308-254-4003 | |
Dr. Kolette L Smith, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Pole Creek Xing, Sidney, NE 69162 Phone: 308-254-5825 |